Seeing Is Believing
with an average price target of $22. This is a potential upside of $16.11 (273.51%) from yesterday's end of day stock price of $5.89.
Moleculin Biotech's activity chart (see below) currently has 19 price targets and 24 ratings on display.
Analysts average stock forecasts to be materialized ratio is 61.54% with an average time for these price targets to be met of 198.46 days.
Highest price target for MBRX is $22, Lowest price target is $22, average price target is $22.
Most recent stock forecast was given by from HC WAINWRIGHT on 24-Mar-2026. First documented stock forecast 13-Nov-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2025
$22
$18.73 (572.78%)
$4
6 months 28 days ago
(24-Mar-2026)
1/2 (50%)
$19.75 (877.78%)
99
Buy Since 09-Jun-2025
$4
$0.73 (22.32%)
$4
1 years 4 months 4 days ago
(18-Jun-2025)
2/2 (100%)
$-10.58 (-72.57%)
188
Buy Since 14-Dec-2023
$8
1 years 6 months 27 days ago
(25-Mar-2025)
3/3 (100%)
$-18.5 (-69.81%)
190
Hold Since 25-Mar-2025
$4
$0.73 (22.32%)
1 years 6 months 27 days ago
(25-Mar-2025)
1/1 (100%)
$-24.75 (-86.09%)
268
Buy Since 14-Apr-2021
$30
$26.73 (817.43%)
2 years 2 months 8 days ago
(14-Aug-2024)
3/3 (100%)
$-32.5 (-52.00%)
380
What is MBRX (Moleculin Biotech) average time for price targets to be met?
Which analyst most recently updated their price target on MBRX (Moleculin Biotech)?
Which analyst has the most public recommendations on MBRX (Moleculin Biotech)?
Which analyst is the currently most bullish on MBRX (Moleculin Biotech)?
Which analyst is the currently most reserved on MBRX (Moleculin Biotech)?